tiprankstipranks
Aquestive Therapeutics (AQST)
NASDAQ:AQST
US Market
Holding AQST?
Track your performance easily

Aquestive Therapeutics (AQST) Technical Analysis

2,084 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Aquestive Therapeutics’s (AQST) Moving Averages Convergence Divergence (MACD) indicator is -0.11, suggesting Aquestive Therapeutics is a Buy.
Aquestive Therapeutics’s (AQST) 20-Day exponential moving average is 4.86, while Aquestive Therapeutics’s (AQST) share price is $4.9, making it a Sell.
Aquestive Therapeutics’s (AQST) 50-Day exponential moving average is 4.82, while Aquestive Therapeutics’s (AQST) share price is $4.9, making it a Sell.

Aquestive Therapeutics (AQST) Pivot Points

Nov 26, 2024, 09:02 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.16
4.27
4.42
4.53
4.68
4.79
4.94
Fibonacci
4.27
4.37
4.43
4.53
4.63
4.69
4.79
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aquestive Therapeutics (AQST) Moving Averages

Nov 26, 2024, 09:02 PM
Period
Simple
Exponential
MA5
4.69Buy
4.69Buy
MA10
4.69Buy
4.75Buy
MA20
4.99Sell
4.86Sell
MA50
4.98Sell
4.82Sell
MA100
4.39Buy
4.48Buy
MA200
3.96Buy
3.96Buy
Aquestive Therapeutics’s (AQST) 10-Day exponential moving average is 4.75, while Aquestive Therapeutics’s (AQST) share price is $4.9, making it a Buy.
Aquestive Therapeutics’s (AQST) 100-Day exponential moving average is 4.48, while Aquestive Therapeutics’s (AQST) share price is $4.9, making it a Buy.
Aquestive Therapeutics’s (AQST) stock price is $4.9 and Aquestive Therapeutics’s (AQST) 50-day simple moving average is 4.98, creating a Sell signal.
Aquestive Therapeutics’s (AQST) stock price is $4.9 and Aquestive Therapeutics’s (AQST) 100-day simple moving average is 4.39, creating a Buy signal.
Aquestive Therapeutics’s (AQST) stock price is $4.9 and Aquestive Therapeutics’s (AQST) 200-day simple moving average is 3.96, creating a Buy signal.

Aquestive Therapeutics (AQST) Technical Indicators

Nov 26, 2024, 09:02 PM
Name
Value
Implied Action
RSI (14)
48.12
Neutral
STOCH (9,6)
30.79
Neutral
STOCHRSI (14)
21.68
Neutral
MACD (12,26)
-0.11
Buy
ADX (14)
13.69
Buy
Williams %R
-63.41
Buy
CCI (14)
-54.15
Neutral
ATR (14)
0.33
-
Ultimate Oscillator
59.64
Neutral
ROC
1.05
Buy
Aquestive Therapeutics’s (AQST) Relative Strength Index (RSI) is 48.12, creating a Neutral signal.
Aquestive Therapeutics’s (AQST) Trend Strength Indicator (ADX) is 13.69, creating a Buy signal.
Aquestive Therapeutics’s (AQST) Commodity Channel Index (CCI) is -54.15, creating a Neutral signal.
Aquestive Therapeutics’s (AQST) Price Rate of Change (ROC) is 1.05, creating a Buy signal.

FAQ

Is AQST a Buy, Hold, or Sell?
Based on AQST’s technical indicators, AQST is a Buy.
    What is AQST’s RSI (14)?
    AQST’s RSI (14) is 48.12, which suggests AQST is a Neutral.
      What is AQST’s MACD?
      AQST’s MACD is -0.11, which suggests AQST is a Buy.
        What is AQST’s 5-day moving average?
        AQST’s 5-day moving average is 4.69, which suggests AQST is a Buy.
          What is AQST’s 20-day moving average?
          AQST 20-day moving average is 4.99, which suggests AQST is a Sell.
            What is AQST’s 50-day moving average?
            AQST’s 50-day moving average is 4.98, which suggests AQST is a Sell.
              What is AQST’s 200-day moving average?
              AQST’s 200-day moving average is 3.96, which suggests AQST is a Buy.
                What is AQST’s Williams % R (14)?
                AQST’s Williams % R (14) is -63.41, which suggests AQST is a Buy.
                  What is AQST’s CCI (14)?
                  AQST’s CCI (14) is -54.15, which suggests AQST is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis